Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again
COLLCollegium Pharmaceutical(COLL) Zacks Investment Research·2024-01-25 02:11

Collegium Pharmaceutical 盈利表现 - 过去两个季度 Collegium Pharmaceutical 的平均盈利超出预期达到 5.67%[2] - Collegium Pharmaceutical 上个季度每股盈利为 1.34，超出ZacksConsensusEstimate1.34，超出 Zacks Consensus Estimate 1.24，意味着盈利超出预期 8.06%[3] - 近期 Collegium Pharmaceutical 的盈利预期有利变化，Zacks Earnings ESP 为正值，显示可能会再次超出预期[4]